Here's what visitors see about you right now.
Your profile on Life Sciences Digital — and the pages for each of your products — were compiled from publicly available materials. We take care to get it right, but nobody knows Graph the way you do, and some of what visitors read today may be out of date or wrong. Claiming the profile lets you correct it directly.
Company description
Graph Safety Suite is an AI-native software platform developed by Graph AI for patient safety and pharmacovigilance in the life sciences industry. The platform is designed to serve pharmaceutical, biotech, cosmetics, and medical device organisations, combining safety monitoring, regulatory compliance, and AI-driven automation into a single connected ecosystem. Graph AI received a $3 million seed round led by Bessemer Venture Partners to scale its AI platforms globally.
The graph safety suite is described as the first GenAI SaaS platform for unified patient safety. It is powered by graphx, Graph AI's proprietary domain-tuned AI foundation, which connects diverse data sources, builds a living knowledge graph, and orchestrates AI reasoning through retrieval, orchestration, and workflow layers. The platform unifies source intake, case processing, aggregate reporting, signal detection, risk management, and regulatory compliance into one integrated system.
Products and Modules
- /intake — Handles multi-channel data ingestion with decoded intelligence across all incoming safety data sources.
- /nucleus — Described as a safety neural network, serving as the core processing and intelligence layer of the platform.
- /assure — Focused on real-time, evidence-driven risk management; scheduled to launch in H2 2026.
- /signal — Provides root causality analysis and clinical context for signal detection; scheduled to launch in H2 2026.
- /report — Delivers AI-drafted, graph-validated regulatory reports; scheduled to launch in H2 2026.
- /comply — Addresses compliance requirements beyond standard regulatory frameworks; scheduled to launch in H2 2026.
Core Platform: graphx
- graphx is Graph AI's proprietary enterprise GenAI platform that unifies fragmented enterprise data and workflows into a context-aware intelligence layer.
- It is built with domain understanding at its core, connecting diverse data sources and building a living knowledge graph.
- The architecture includes retrieval, orchestration, and workflow layers that transform raw data into actionable intelligence.
- graphx is designed to operate securely and compliantly at scale across regulated industries.
- It enables domain-specific AI that adapts and learns, and is described as accelerating time to value while maintaining transparency.
- graphx also powers plug-and-play GenAI pipelines with built-in domain intelligence for pharma, biotech, cosmetics, and medical devices beyond the safety suite.
Key Capabilities
- Unified, AI-native architecture replacing fragmented legacy systems.
- Collaborative functional system with automation across safety workflows.
- Agentic and generative AI intelligence embedded throughout the platform.
- API-first and integration-ready ecosystem.
- Systematic signal management assisted by generative AI.
- Proactive risk management capabilities.
- Dynamic knowledge graph for connected data intelligence.
- Built-in compliance and audit readiness with explainable AI.
- User-centric workflow design and collaborative platform environment.
- Insight-driven decision support across safety functions.
Reported Performance Metrics
- Productivity gains of approximately 70% through intelligent automation.
- Cost reduction of 55% or more.
- Efficiency gains exceeding 80%.
- Regulatory reporting accuracy above 99%.
- Industry-leading AI accuracy and completeness for safety data processing.
- Audit-ready outputs with compliance embedded throughout the platform.
Compliance and Trust
- The platform is built to meet regulatory requirements across the life sciences sector.
- AI outputs are designed to be explainable and traceable, supporting regulatory confidence.
- Complete, traceable data is maintained for every safety process.
- The system is positioned as audit-ready by design, with compliance embedded natively rather than added as a layer.
Graph AI positions the graph safety suite as an alternative to legacy pharmacovigilance systems, offering a fully integrated, AI-native approach to patient safety that covers the full spectrum of safety functions from data intake through to regulatory reporting and risk management.
AI-generated · replace with your own
Every part of your profile.
Your company page and every software page attached to it. Nothing is held back — a premium profile includes all of it.
Accuracy
Your own descriptions
Replace the AI-generated summary with your own words — for your company and for every product you list.

Discovery
Classification & search
List your software under up to three domains and subdomains, and appear in search as a company, not only as a product.

Evidence
Case studies
Published outcomes with images and links to the full write-up. Add as many as you need, edit them anytime.

Product
Image gallery
Screenshots of the actual interface, in a gallery visitors can open full-size.

Next step
Call-to-action
A dedicated block that sends visitors where you want them — a demo, a trial, or a contact form.

And more:
Basic listing vs premium profile
There are no tiers. Everything below is included with a premium profile, across your company page and every software page attached to it.
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Basic
Premium
Three steps away.
01
You reach out
Fill in the form below with a few details about your company.
02
We talk
A short call or an email thread, whichever you prefer. We answer your questions and agree on the details.
03
You get access
We set up your login. From there you can edit everything and publish when you are ready.
Ready to claim the Graph profile?
Send a short note and we will get back to you.